Our study reveals a functional role of CD157 in pro-survival signaling in AML cells and provides a rationale for the use of CD157 as a predictive marker of response to therapies exploiting Mcl-1 pharmacological inhibition. The gene discussed is BST1; the disease is acute myeloid leukemia.